Aspergillus oryzae NK |
strong wakamoto w |
Study of the mechanisms of a Japanese traditional fermented medicine in the improvement of constipation. |
Bacillus coagulans GBI-30 |
Schiff® Digestive Advantage® Daily Probiotic |
Different effects of Bacillus coagulans vegetative cells and spore isolates on constipation-induced gut microbiota dysbiosis in mice. |
Bifidobacterium animalis subsp lactis HN019 |
Optibac Every Day Max |
Effects of 28-day Bifidobacterium animalis subsp. lactis HN019 supplementation on colonic transit time and gastrointestinal symptoms in adults with functional constipation: A double-blind, randomized, placebo-controlled, and dose-ranging trial. |
Bifidobacterium animalis subsp lactis HN019 |
Optibac Every Day Max |
The effect of a probiotic blend on gastrointestinal symptoms in constipated patients: a double blind, randomised, placebo controlled 2-week trial. |
Bifidobacterium bifidum G9-1 (BBG9-1) |
Phillips'® Colon Health |
Alleviation of low-fiber diet-induced constipation by probiotic <i>Bifidobacterium bifidum</i> G9-1 is based on correction of gut microbiota dysbiosis. |
Bifidobacterium bifidum G9-1 (BBG9-1) |
Phillips'® Colon Health |
Correction: Improvement of loperamide-induced slow transit constipation by Bifidobacterium bifidum G9-1 is mediated by the correction of butyrate production and neurotransmitter profile due to improvement in dysbiosis. |
Bifidobacterium bifidum G9-1 (BBG9-1) |
Phillips'® Colon Health |
Corrigendum: Alleviation of low-fiber diet-induced constipation by probiotic Bifidobacterium bifidum G9-1 is based on correction of gut microbiota dysbiosis. |
Bifidobacterium bifidum G9-1 (BBG9-1) |
Phillips'® Colon Health |
Effect of probiotics, <i>Bifidobacterium bifidum</i> G9-1, on gastrointestinal symptoms in patients with type 2 diabetes mellitus: study protocol for open-label, single-arm, exploratory research trial (Big STAR study). |
Bifidobacterium bifidum G9-1 (BBG9-1) |
Phillips'® Colon Health |
Efficacy of Bifidobacterium bifidum G9-1 in improving quality of life in patients with chronic constipation: a prospective intervention study. |
Bifidobacterium bifidum G9-1 (BBG9-1) |
Phillips'® Colon Health |
Improvement of loperamide-induced slow transit constipation by Bifidobacterium bifidum G9-1 is mediated by the correction of butyrate production and neurotransmitter profile due to improvement in dysbiosis. |
Bifidobacterium bifidum G9-1 (BBG9-1) |
Phillips'® Colon Health |
Probiotic Bifidobacterium bifidum G9-1 attenuates 5-fluorouracil-induced intestinal mucositis in mice via suppression of dysbiosis-related secondary inflammatory responses. |
Bifidobacterium bifidum W23 |
Ecologic® Barrier for Metabolic Health |
Is a multispecies probiotic mixture effective in constipation during pregnancy? `A pilot study`. |
Bifidobacterium lactis BB-12 |
Nestlé |
[Effect of probiotics on the dynamics of gastrointestinal symptoms of food allergy to cow`s milk protein in infants]. |
Bifidobacterium lactis BB-12 |
Nestlé |
Beneficial effects of a synbiotic supplement on self-perceived gastrointestinal well-being and immunoinflammatory status of healthy adults. |
Bifidobacterium lactis Bi-07 |
UltraFlora® Balance |
A combination of three probiotic strains for treatment of acute diarrhoea in hospitalised children: an open label, randomised controlled trial. |
Bifidobacterium lactis Bi-07 |
UltraFlora® Balance |
Effect of the consumption of a cheese enriched with probiotic organisms (Bifidobacterium lactis bi-07) in improving symptoms of constipation. |
Bifidobacterium lactis Bi-07 |
UltraFlora® Balance |
Probiotic bacteria Lactobacillus acidophilus NCFM and Bifidobacterium lactis Bi-07 versus placebo for the symptoms of bloating in patients with functional bowel disorders: a double-blind study. |
Bifidobacterium lactis Bi-07 |
UltraFlora® Balance |
The effect of a probiotic blend on gastrointestinal symptoms in constipated patients: a double blind, randomised, placebo controlled 2-week trial. |
Bifidobacterium lactis W51 |
Ecologic® Barrier for Metabolic Health |
Is a multispecies probiotic mixture effective in constipation during pregnancy? `A pilot study`. |
Bifidobacterium lactis W52 |
Ecologic® Barrier for Metabolic Health |
Is a multispecies probiotic mixture effective in constipation during pregnancy? `A pilot study`. |
Bifidobacterium longum BB536 |
Probiotic Pro Bb536 |
Effects of <i>Bifidobacterium longum</i> and <i>Lactobacillus rhamnosus</i> on Gut Microbiota in Patients with Lactose Intolerance and Persisting Functional Gastrointestinal Symptoms: A Randomised, Double-Blind, Cross-Over Study. |
Bifidobacterium longum BB536 |
Probiotic Pro Bb536 |
Efficacy of a mixture of probiotic agents as complementary therapy for chronic functional constipation in childhood. |
Bifidobacterium longum R0175 |
Calm Biotic® |
Efficacy of <i>Lactobacillus paracasei</i> HA-196 and <i>Bifidobacterium longum</i> R0175 in Alleviating Symptoms of Irritable Bowel Syndrome (IBS): A Randomized, Placebo-Controlled Study. |
Bifidobacterium longum subsp. infantis NLS |
Life Start 2 |
Exploratory, randomized, double-blind, placebo-controlled study on the effects of Bifidobacterium infantis natren life start strain super strain in active celiac disease. |
Bifidobacterium longum W108 |
Ecologic® Relief |
Is a multispecies probiotic mixture effective in constipation during pregnancy? `A pilot study`. |
Lactobacillus acidophilus CL1285 |
Bio-K+ |
Lactobacillus acidophilus CL1285, Lactobacillus casei LBC80R and Lactobacillus rhamnosus CLR2 improve quality-of-life and IBS symptoms: a double-blind, randomised, placebo-controlled study. |
Lactobacillus acidophilus NCFM |
UltraFlora® Balance |
A combination of three probiotic strains for treatment of acute diarrhoea in hospitalised children: an open label, randomised controlled trial. |
Lactobacillus acidophilus NCFM |
UltraFlora® Balance |
Effect of yogurt containing polydextrose, Lactobacillus acidophilus NCFM and Bifidobacterium lactis HN019: a randomized, double-blind, controlled study in chronic constipation. |
Lactobacillus acidophilus NCFM |
UltraFlora® Balance |
EFFECTS OF SYNBIOTIC SUPPLEMENTATION ON GUT FUNCTIONING AND SYSTEMIC INFLAMMATION OF COMMUNITY-DWELLING ELDERS - SECONDARY ANALYSES FROM A RANDOMIZED CLINICAL TRIAL. |
Lactobacillus acidophilus NCFM |
UltraFlora® Balance |
Probiotic bacteria Lactobacillus acidophilus NCFM and Bifidobacterium lactis Bi-07 versus placebo for the symptoms of bloating in patients with functional bowel disorders: a double-blind study. |
Lactobacillus acidophilus NCFM |
UltraFlora® Balance |
The effect of a probiotic blend on gastrointestinal symptoms in constipated patients: a double blind, randomised, placebo controlled 2-week trial. |
Lactobacillus casei LBC80R |
Bio-K+ |
Lactobacillus acidophilus CL1285, Lactobacillus casei LBC80R and Lactobacillus rhamnosus CLR2 improve quality-of-life and IBS symptoms: a double-blind, randomised, placebo-controlled study. |
Lactobacillus casei Shirota |
Yakult |
[Probiotics as therapeutic agents in irritable bowel syndrome]. |
Lactobacillus casei Shirota |
Yakult |
<i>Lactobacillus casei</i> Strain Shirota Alleviates Constipation in Adults by Increasing the Pipecolinic Acid Level in the Gut. |
Lactobacillus casei Shirota |
Yakult |
Differential Effects of <i>Lactobacillus casei</i> Strain Shirota on Patients With Constipation Regarding Stool Consistency in China. |
Lactobacillus casei Shirota |
Yakult |
Effect of fermented milk containing Lactobacillus casei strain Shirota on constipation-related symptoms and haemorrhoids in women during puerperium. |
Lactobacillus casei Shirota |
Yakult |
Effects of a probiotic fermented milk on functional constipation: a randomized, double-blind, placebo-controlled study. |
Lactobacillus casei Shirota |
Yakult |
Effects of Fermented Milk Containing Lacticaseibacillus paracasei Strain Shirota on Constipation in Patients with Depression: A Randomized, Double-Blind, Placebo-Controlled Trial. |
Lactobacillus casei Shirota |
Yakult |
Effects of synbiotic treatment on serum level of p-cresol in haemodialysis patients: a preliminary study. |
Lactobacillus casei Shirota |
Yakult |
Effects of the continuous intake of a milk drink containing Lactobacillus casei strain Shirota on abdominal symptoms, fecal microbiota, and metabolites in gastrectomized subjects. |
Lactobacillus casei Shirota |
Yakult |
Efficacy of probiotics on digestive disorders and acute respiratory infections: a controlled clinical trial in young Vietnamese children. |
Lactobacillus casei Shirota |
Yakult |
Fermented milk containing Lactobacillus casei strain Shirota reduces incidence of hard or lumpy stools in healthy population. |
Lactobacillus casei Shirota |
Yakult |
Improving the bowel habits of elderly residents in a nursing home using probiotic fermented milk. |
Lactobacillus casei Shirota |
Yakult |
Probiotic beverage containing Lactobacillus casei Shirota improves gastrointestinal symptoms in patients with chronic constipation. |
Lactobacillus casei Shirota |
Yakult |
Probiotics and synbiotics in chronic constipation in adults: A systematic review and meta-analysis of randomized controlled trials. |
Lactobacillus casei Shirota |
Yakult |
Systematic review of randomised controlled trials: probiotics for functional constipation. |
Lactobacillus casei Shirota |
Yakult |
The effect of probiotics on functional constipation in adults: a systematic review and meta-analysis of randomized controlled trials. |
Lactobacillus casei Shirota |
Yakult |
Use of probiotics for the treatment of constipation in Parkinson`s disease patients. |
Lactobacillus casei W79 |
Ecologic® Relief |
Is a multispecies probiotic mixture effective in constipation during pregnancy? `A pilot study`. |
Lactobacillus paracasei Lpc-37 |
Custom Probiotics |
The effect of a probiotic blend on gastrointestinal symptoms in constipated patients: a double blind, randomised, placebo controlled 2-week trial. |
Lactobacillus plantarum 299v |
Jarrow Formulas Ideal Bowel Support |
[Irritable bowel syndrome--irritable bowel or irritable mind?]. |
Lactobacillus plantarum 299v |
Jarrow Formulas Ideal Bowel Support |
[Treatment of IBS with Lactobacillus plantarum 299v: Therapeutic success increases with length of treatment - real-life data of a non-interventional study in Germany]. |
Lactobacillus plantarum W62 |
Ecologic® AAD |
Is a multispecies probiotic mixture effective in constipation during pregnancy? `A pilot study`. |
Lactobacillus reuteri DSM 17938 |
BioGaia® |
"The role of L. reuteri DSM17938 in nutritional recovery and treatment of constipation in children and adolescents with anorexia nervosa - a randomized, double blind, placebo controlled study". |
Lactobacillus reuteri DSM 17938 |
BioGaia® |
<i>Lactobacillus reuteri</i> DSM 17938 and Agave Inulin in Children with Cerebral Palsy and Chronic Constipation: A Double-Blind Randomized Placebo Controlled Clinical Trial. |
Lactobacillus reuteri DSM 17938 |
BioGaia® |
Effect of Lactobacillus reuteri (DSM 17938) on methane production in patients affected by functional constipation: a retrospective study. |
Lactobacillus reuteri DSM 17938 |
BioGaia® |
Effectiveness of Probiotics in Children With Functional Abdominal Pain Disorders and Functional Constipation: A Systematic Review. |
Lactobacillus reuteri DSM 17938 |
BioGaia® |
Effects of long-term administration of Lactobacillus reuteri DSM-17938 on circulating levels of 5-HT and BDNF in adults with functional constipation. |
Lactobacillus reuteri DSM 17938 |
BioGaia® |
Lack of Benefit of Lactobacillus reuteri DSM 17938 as an Addition to the Treatment of Functional Constipation. |
Lactobacillus reuteri DSM 17938 |
BioGaia® |
Lactobacillus reuteri (DSM 17938) in infants with functional chronic constipation: a double-blind, randomized, placebo-controlled study. |
Lactobacillus reuteri DSM 17938 |
BioGaia® |
Lactobacillus Reuteri DSM 17938 (Limosilactobacillus reuteri) in Diarrhea and Constipation: Two Sides of the Same Coin? |
Lactobacillus reuteri DSM 17938 |
BioGaia® |
Lactobacillus reuteri DSM 17938 and Magnesium Oxide in Children with Functional Chronic Constipation: A Double-Blind and Randomized Clinical Trial. |
Lactobacillus reuteri DSM 17938 |
BioGaia® |
Microvesicles from Lactobacillus reuteri (DSM-17938) completely reproduce modulation of gut motility by bacteria in mice. |
Lactobacillus reuteri DSM 17938 |
BioGaia® |
Probiotics in Functional Gastrointestinal Disorders. |
Lactobacillus reuteri DSM 17938 |
BioGaia® |
Probiotics on Pediatric Functional Gastrointestinal Disorders. |
Lactobacillus reuteri DSM 17938 |
BioGaia® |
Probiotics, prebiotics, and dietary fiber in the management of functional gastrointestinal disorders. |
Lactobacillus reuteri DSM 17938 |
BioGaia® |
Prophylactic use of a probiotic in the prevention of colic, regurgitation, and functional constipation: a randomized clinical trial. |
Lactobacillus reuteri DSM 17938 |
BioGaia® |
Randomised double blind placebo controlled trial on Lactobacillus reuteri DSM 17938: improvement in symptoms and bowel habit in functional constipation. |
Lactobacillus reuteri DSM 17938 |
BioGaia® |
The effect of Lactobacillus reuteri supplementation in adults with chronic functional constipation: a randomized, double-blind, placebo-controlled trial. |
Lactobacillus reuteri DSM 17938 |
BioGaia® |
The effectiveness of Lactobacillus reuteri DSM 17938 as an adjunct to macrogol in the treatment of functional constipation in children. A randomized, double-blind, placebo-controlled, multicentre trial. |
Lactobacillus reuteri DSM 17938 |
BioGaia® |
The efficacy of Lactobacillus reuteri DSM 17938 in infants and children: a review of the current evidence. |
Lactobacillus reuteri DSM 17938 |
BioGaia® |
The good bugs: the use of probiotics in pediatrics. |
Lactobacillus reuteri DSM 17938 |
BioGaia® |
The use of probiotics in pediatric gastroenterology: a review of the literature and recommendations by Latin-American experts. |
Lactobacillus rhamnosus CLR2 |
Bio-K+ |
Lactobacillus acidophilus CL1285, Lactobacillus casei LBC80R and Lactobacillus rhamnosus CLR2 improve quality-of-life and IBS symptoms: a double-blind, randomised, placebo-controlled study. |
Lactobacillus rhamnosus GG |
Culturelle® |
[Administration of probiotic lactobacilli to children with gastrointestinal problems: there is still little evidence]. |
Lactobacillus rhamnosus GG |
Culturelle® |
Bugs and Guts: Practical Applications of Probiotics for Gastrointestinal Disorders in Children. |
Lactobacillus rhamnosus GG |
Culturelle® |
Constipation is relieved more by rye bread than wheat bread or laxatives without increased adverse gastrointestinal effects. |
Lactobacillus rhamnosus GG |
Culturelle® |
Cytokine-specific autoantibodies shape the gut microbiome in autoimmune polyendocrine syndrome type 1. |
Lactobacillus rhamnosus GG |
Culturelle® |
Decrease of Postchemotherapy Complications With the Use of Probiotics in Children With Acute Lymphoblastic Leukemia. |
Lactobacillus rhamnosus GG |
Culturelle® |
Effectiveness of Probiotics in Children With Functional Abdominal Pain Disorders and Functional Constipation: A Systematic Review. |
Lactobacillus rhamnosus GG |
Culturelle® |
Investigation of the Efficacy of Lactobacillus rhamnosus GG in Infants With Cow`s Milk Protein Allergy: a Randomised Double-Blind Placebo-Controlled Trial. |
Lactobacillus rhamnosus GG |
Culturelle® |
Probiotics in Functional Gastrointestinal Disorders. |
Lactobacillus rhamnosus GG |
Culturelle® |
Risk and Protective Factors for Gastrointestinal Symptoms associated with Antibiotic Treatment in Children: A Population Study. |
Lactobacillus rhamnosus GG |
Culturelle® |
Synbiotic yogurt consumption by healthy adults and the elderly: the fate of bifidobacteria and LGG probiotic strain. |
Lactobacillus rhamnosus GG |
Culturelle® |
Systematic review of randomised controlled trials: probiotics for functional constipation. |
Lactobacillus rhamnosus GG |
Culturelle® |
The good bugs: the use of probiotics in pediatrics. |
Lactobacillus rhamnosus GG |
Culturelle® |
The use of probiotics in pediatric gastroenterology: a review of the literature and recommendations by Latin-American experts. |
Lactobacillus rhamnosus Lcr35 |
Provacare® |
Effectiveness of Probiotics in Children With Functional Abdominal Pain Disorders and Functional Constipation: A Systematic Review. |
Lactobacillus rhamnosus Lcr35 |
Provacare® |
Lactobacillus casei rhamnosus Lcr35 in children with chronic constipation. |
Lactobacillus rhamnosus Lcr35 |
Provacare® |
Lactobacillus casei rhamnosus Lcr35 in the Management of Functional Constipation in Children: A Randomized Trial. |
Lactobacillus rhamnosus Lcr35 |
Provacare® |
Systematic review of randomised controlled trials: probiotics for functional constipation. |
Lactobacillus rhamnosus Lcr35 |
Provacare® |
Systematic review: probiotics for functional constipation in children. |
Lactobacillus rhamnosus W71 |
Ecologic® AAD |
Is a multispecies probiotic mixture effective in constipation during pregnancy? `A pilot study`. |
Mutaflor (Escherichia coli strain Nissle 1917) |
Mutaflor (Canada, Australia, Findland, Germany) |
[Probiotic drug therapy with E. coli strain Nissle 1917 (EcN): results of a prospective study of the records of 3,807 patients]. |
Mutaflor (Escherichia coli strain Nissle 1917) |
Mutaflor (Canada, Australia, Findland, Germany) |
[Treatment of chronic constipation with physiologic Escherichia coli bacteria. Results of a clinical study of the effectiveness and tolerance of microbiological therapy with the E. coli Nissle 1917 strain (Mutaflor)]. |
Mutaflor (Escherichia coli strain Nissle 1917) |
Mutaflor (Canada, Australia, Findland, Germany) |
[Treatment of irritable bowel syndrome with Escherichia coli strain Nissle 1917 (EcN): a retrospective survey]. |
Mutaflor (Escherichia coli strain Nissle 1917) |
Mutaflor (Canada, Australia, Findland, Germany) |
Efficacy of Probiotic Escherichia coli Nissle 1917 in Patients with Irritable Bowel Syndrome: a Double Blind Placebo-controlled Randomized Trial. |
Mutaflor (Escherichia coli strain Nissle 1917) |
Mutaflor (Canada, Australia, Findland, Germany) |
Probiotic Escherichia coli Nissle 1917 and commensal E. coli K12 differentially affect the inflammasome in intestinal epithelial cells. |
Symbioflor 2 |
German Apotheke by Paul's Mart |
Probiotic treatment of irritable bowel syndrome in children. |
VSL3 / Visbiome / De Simone Formulation |
Alfasigma USA, Inc. |
[The role of oral probiotic for bacterial vaginosis in pregnant women. A pilot study]. |